Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z7200 vs Symbicort® Turbohaler in Asthmatic Patients
NCT02227394Phase 2Completed
- Sponsor
- Zambon
- Start
- Aug 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide + formoterol in asthma, sponsored by Zambon. Primary endpoint: Total Airway Volume. Started Aug 2014; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02227394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227394.